Fluid and Electrolyte Physiology
Total body water (TBW) is approximately 60% body weight in males, 50% in females, 65-70% in infants, 50% in elderly. Distribution : 2/3 intracellular (ICF), 1/3 extracellular (ECF). ECF divided into interstitial fluid...
Clinical board
A visual summary of the highest-yield teaching signals on this page.
Urgent signals
Safety-critical features pulled from the topic metadata.
- Severe hyponatremia (<120 mmol/L) with neurological symptoms
- Severe hypernatremia (>160 mmol/L)
- Severe hypokalemia (<2.5 mmol/L) with ECG changes
- Severe hyperkalemia (>6.5 mmol/L) with peaked T waves
Exam focus
Current exam surfaces linked to this topic.
- ANZCA Primary Written
- ANZCA Primary Viva
Editorial and exam context
Quick Answer
Total body water (TBW) is approximately 60% body weight in males, 50% in females, 65-70% in infants, 50% in elderly. Distribution: 2/3 intracellular (ICF), 1/3 extracellular (ECF). ECF divided into interstitial fluid (ISF, 3/4) and plasma (1/4). Osmolality: 285-295 mOsm/kg (regulated by ADH, thirst). Sodium: Primary extracellular cation (135-145 mmol/L), maintains ECF osmolality and volume. Potassium: Primary intracellular cation (3.5-5.0 mmol/L), critical for resting membrane potential. Calcium: 2.2-2.6 mmol/L total (50% free/ionized), essential for neuromuscular function, coagulation, cardiac contractility. Magnesium: 0.75-0.95 mmol/L, cofactor for ATPases. Chloride: 95-105 mmol/L, main extracellular anion. Fluid shifts: Follow osmotic gradients (water moves from low to high osmolality). Starling forces: Determine transcapillary fluid exchange (hydrostatic vs oncotic pressure). Anaesthetic implications: Preoperative fasting deficits, third space losses, blood loss replacement, glucose management, fluid overload prevention. [1-10]
Body Water Distribution
Total Body Water (TBW)
Percentage of Body Weight:
- Adult males: 60% (60 kg in 70 kg male)
- Adult females: 50-55% (35-38 L in 70 kg female)
- Lower due to higher body fat percentage
- Infants: 65-70% (higher water content)
- Elderly: 50% (decreased muscle mass)
- Obesity: Lower percentage (fat has low water content)
Compartments:
1. Intracellular Fluid (ICF):
- Volume: 40% body weight (2/3 of TBW)
- Location: Inside all cells
- Composition:
- High potassium (140 mmol/L)
- Low sodium (10-15 mmol/L)
- High magnesium (40 mmol/L)
- High phosphate and protein anions
- Osmolality: 285-295 mOsm/kg (same as ECF)
2. Extracellular Fluid (ECF):
- Volume: 20% body weight (1/3 of TBW)
- Subcompartments:
- Interstitial fluid (ISF): 15% body weight (75% of ECF)
- Between cells, outside vessels
- Plasma: 5% body weight (25% of ECF)
- Intravascular fluid
- Transcellular fluid: Small volume (CSF, synovial, pleural, peritoneal)
- Interstitial fluid (ISF): 15% body weight (75% of ECF)
Summary Table:
| Compartment | % Body Weight | % TBW | Volume (70 kg male) |
|---|---|---|---|
| ICF | 40% | 67% | 28 L |
| ECF | 20% | 33% | 14 L |
| - Interstitial | 15% | 25% | 10.5 L |
| - Plasma | 5% | 8% | 3.5 L |
| Total | 60% | 100% | 42 L |
Gibbs-Donnan Effect:
- Principle: Non-diffusible anions (proteins) in plasma create unequal distribution of diffusible ions
- Effect: Slightly higher chloride and bicarbonate in ISF vs plasma
- Result: Plasma has slightly higher osmotic pressure than ISF (oncotic pressure)
Electrolyte Physiology
Sodium (Na⁺)
Physiological Role:
- Primary extracellular cation: 135-145 mmol/L (plasma)
- Osmolality maintenance: Primary determinant of ECF osmolality (Posm ≈ 2[Na⁺] + glucose/18 + BUN/2.8)
- ECF volume: Determines ECF volume (water follows osmotic gradients)
- Resting membrane potential: Contributes (less than K⁺)
- Acid-base balance: Na⁺ reabsorption linked to H⁺ secretion
Daily Requirements:
- Intake: 1-2 mmol/kg/day (70-140 mmol for 70 kg adult)
- Distribution: 98% extracellular
- Regulation:
- Aldosterone: Na⁺ retention (distal tubule)
- ADH: Water retention (collecting duct)
- ANP: Na⁺ excretion (atria)
Clinical Disorders:
Hyponatremia (<135 mmol/L):
- Symptoms: Headache, nausea, confusion, seizures, coma (if <120 mmol/L or rapid decline)
- Classification by volume status:
- Hypovolemic: Loss of Na⁺ and water (diuretics, vomiting, Addison's)
- Euvolemic: Water excess (SIADH, hypothyroidism, cortisol deficiency)
- Hypervolemic: Edema states (heart failure, cirrhosis, nephrotic syndrome)
- Treatment: Depends on cause and severity
- Acute symptomatic: 3% NaCl (100 mL bolus)
- Chronic: Slow correction (max 8-12 mmol/L/day to avoid osmotic demyelination)
Hypernatremia (>145 mmol/L):
- Symptoms: Thirst, confusion, seizures, coma (if >160 mmol/L)
- Mechanism: Water deficit or Na⁺ excess
- Treatment: Free water replacement (oral or IV D5W)
Potassium (K⁺)
Physiological Role:
- Primary intracellular cation: 140 mmol/L (ICF), 3.5-5.0 mmol/L (ECF)
- Resting membrane potential: Primary determinant (Nernst equation)
- Hyperkalemia: Depolarization (excitable tissues)
- Hypokalemia: Hyperpolarization (weakness)
- Cardiac conduction: Critical (ECG changes with K⁺ disturbances)
- Acid-base: K⁺ shifts with H⁺ (acidosis → hyperkalemia, alkalosis → hypokalemia)
Daily Requirements:
- Intake: 1 mmol/kg/day (70 mmol for 70 kg adult)
- Regulation:
- Insulin: Drives K⁺ into cells
- Catecholamines (β-2): Drive K⁺ into cells
- Aldosterone: K⁺ excretion (distal tubule)
- Acid-base status: Affects distribution
Clinical Disorders:
Hypokalemia (<3.5 mmol/L):
- Causes: Diuretics, vomiting, diarrhea, alkalosis, insulin, β-agonists
- ECG: Flattened T waves, ST depression, U waves, prolonged QT
- Effects: Muscle weakness, ileus, arrhythmias (especially with digoxin)
- Treatment: Oral preferred, IV if severe (max 20 mmol/hour via central line)
Hyperkalemia (>5.0 mmol/L):
- Causes: Renal failure, acidosis, cell lysis, K⁺ sparing diuretics, ACE inhibitors
- ECG: Peaked T waves, widened QRS, sine wave, VF/asystole
- Emergency treatment:
- Calcium (stabilize membrane)
- Insulin/glucose (shift K⁺ intracellular)
- Bicarbonate (if acidotic)
- β-agonists (salbutamol)
- Dialysis (if refractory)
Calcium (Ca²⁺)
Physiological Role:
- Total calcium: 2.2-2.6 mmol/L (plasma)
- Ionized (free): 50% (1.1-1.3 mmol/L) - physiologically active
- Protein-bound: 40% (mostly albumin)
- Complexed: 10% (with phosphate, citrate, bicarbonate)
- Albumin correction: [Ca²⁺] decreases 0.02 mmol/L per 1 g/L decrease in albumin (below 40 g/L)
Functions:
- Neuromuscular: Neurotransmitter release, muscle contraction
- Cardiac: Contractility, conduction
- Coagulation: Factor IV (required for multiple steps)
- Bone: Structural (hydroxyapatite)
- Intracellular signaling: Second messenger
Regulation:
- Parathyroid hormone (PTH): Increases Ca²⁺ (bone resorption, renal reabsorption, intestinal absorption via vitamin D)
- Vitamin D: Increases Ca²⁺ absorption
- Calcitonin: Decreases Ca²⁺ (bone uptake)
Clinical Disorders:
Hypocalcemia (<2.2 mmol/L total, <1.1 mmol/L ionized):
- Causes: Hypoparathyroidism, vitamin D deficiency, hypomagnesemia, citrate (massive transfusion), alkalosis (↓ionized)
- Symptoms: Tetany, Chvostek's sign, Trousseau's sign, seizures, hypotension
- ECG: Prolonged QT interval
- Treatment: Calcium chloride or gluconate IV, magnesium if low
Hypercalcemia (>2.6 mmol/L):
- Causes: Malignancy, hyperparathyroidism, sarcoidosis, immobilization
- Symptoms: "Bones, stones, groans, moans, psychic overtones"
- Treatment: Hydration, bisphosphonates, calcitonin, steroids
Magnesium (Mg²⁺)
Physiological Role:
- Concentration: 0.75-0.95 mmol/L (plasma), 15 mmol/L (ICF)
- Cofactor: ATPases (Na⁺/K⁺-ATPase, Ca²⁺-ATPase)
- Enzyme activation: >300 enzymes
- Neuromuscular: Required for PTH release, modulates NMDA receptors
- Cardiac: Antiarrhythmic (class effect)
Clinical Disorders:
Hypomagnesemia (<0.75 mmol/L):
- Causes: Diuretics, alcoholism, malabsorption, proton pump inhibitors
- Effects: Refractory hypokalemia and hypocalcemia, tremor, seizures, arrhythmias (torsades de pointes)
- Treatment: Magnesium sulfate IV (1-2 g over 15 min, then infusion)
Hypermagnesemia (>1.1 mmol/L):
- Causes: Renal failure, magnesium administration (tocolysis, preeclampsia)
- Effects: Neuromuscular blockade, hypotension, bradycardia, respiratory depression
- Treatment: Calcium antagonist, dialysis if severe
Chloride (Cl⁻)
Physiological Role:
- Concentration: 95-105 mmol/L (plasma), major extracellular anion
- Acid-base balance:
- Hypochloremic alkalosis: With vomiting (lose HCl), diuretics
- Hyperchloremic acidosis: With saline administration (dilutional)
- Strong ion difference: Part of Stewart approach to acid-base
Phosphate (PO₄³⁻)
Physiological Role:
- Concentration: 0.8-1.4 mmol/L (plasma)
- Functions: ATP, 2,3-DPG, bone mineralization, cellular signaling
- Clinical: Hypophosphatemia with refeeding syndrome, hyperphosphatemia in renal failure
Fluid Physiology
Osmolality and Tonicity
Osmolality:
- Definition: Number of osmotically active particles per kg solvent (mOsm/kg)
- Normal plasma osmolality: 285-295 mOsm/kg
- Calculation: 2[Na⁺] + [glucose]/18 + [urea]/2.8 (normal glucose and urea contribute ~10 mOsm/kg)
- ICF and ECF osmolality: Equal (water moves freely across cell membranes)
Tonicity (Effective Osmolality):
- Definition: Osmolality that causes water movement (excludes urea which crosses membranes freely)
- Effective osmoles: Na⁺, glucose, mannitol (do not cross membranes easily)
- Ineffective osmoles: Urea, ethanol (cross freely, equilibrate)
- Clinical importance: Tonicity determines cell volume (brain cells swell in hypotonic states)
Regulation of Fluid Balance
Thirst Mechanism:
- Stimulus: ↑plasma osmolality (>295 mOsm/kg), ↓ECF volume
- Response: Water intake
- ADH release: Simultaneous with thirst
Antidiuretic Hormone (ADH/Vasopressin):
- Source: Posterior pituitary (synthesized in hypothalamus)
- Stimuli:
- Osmotic: ↑plasma osmolality (very sensitive, 1% change triggers)
- Volume: ↓ECF volume >10% (less sensitive)
- Action: Aquaporin-2 insertion in collecting duct → water reabsorption
- Result: Concentrated urine, water retention
Aldosterone:
- Source: Adrenal cortex (zona glomerulosa)
- Stimuli: ↓Na⁺, ↓ECF volume, ↑K⁺, angiotensin II
- Action: Na⁺ reabsorption, K⁺ excretion (distal tubule)
- Result: Volume expansion
Natriuretic Peptides (ANP, BNP):
- Source: Atria (ANP) and ventricles (BNP)
- Stimuli: Atrial stretch (volume overload)
- Action: Na⁺ and water excretion, vasodilation
- Result: Volume reduction
Capillary Fluid Exchange
Starling Forces:
Forces moving fluid OUT of capillary (filtration):
- Capillary hydrostatic pressure (Pc): 30-35 mmHg (arterial end), 10-15 mmHg (venous end)
- Interstitial oncotic pressure (πi): 5 mmHg (minimal protein in ISF)
Forces moving fluid INTO capillary (reabsorption):
- Interstitial hydrostatic pressure (Pi): -2 to -5 mmHg (negative due to lymphatic drainage)
- Capillary oncotic pressure (πc): 25-28 mmHg (albumin)
Net filtration pressure (arterial end): = (Pc + πi) - (Pi + πc) = (30 + 5) - (-3 + 25) = 35 - 22 = +13 mmHg (filtration)
Net reabsorption pressure (venous end): = (15 + 5) - (-3 + 25) = 20 - 22 = -2 mmHg (reabsorption)
Clinical Implications:
- Increased Pc (venous congestion): Edema (heart failure, fluid overload)
- Decreased πc (hypoalbuminemia): Edema (liver disease, nephrotic syndrome)
- Increased capillary permeability: Edema (sepsis, burns, inflammation)
- Lymphatic obstruction: Edema (filariasis, malignancy)
Anaesthetic Implications
Preoperative Fluid Management
Fasting Deficit:
- Standard calculation: Hourly maintenance × hours fasting
- Maintenance (4-2-1 rule):
- First 10 kg: 4 mL/kg/hour
- Next 10 kg: 2 mL/kg/hour
- Remaining weight: 1 mL/kg/hour
- Example: 70 kg patient NPO 8 hours
- Hourly: 40 + 20 + 50 = 110 mL/hour
- Deficit: 110 × 8 = 880 mL
- Replace 50% in first hour, 25% in next 2 hours
Fluid Choice for Deficit:
- Isotonic crystalloid: 0.9% saline, Hartmann's, Plasma-Lyte
- Avoid hypotonic: D5W, 0.45% saline (post-neonatal period)
Intraoperative Fluid Therapy
Goals:
- Replace fasting deficit
- Replace ongoing losses (blood, third space, evaporation)
- Maintain perfusion (BP, urine output, lactate)
- Avoid fluid overload
Types of Fluid Loss:
1. Sensible Losses:
- Blood loss: Measure (suction, sponges), replace
- <500 mL: Crystalloid (3:1 ratio)
-
500 mL: Consider colloid or blood
- Urine output: Monitor, maintain >0.5 mL/kg/hour
- Evaporation: From surgical field (variable)
2. Insensible Losses:
- Respiratory: Humidified gases reduce loss
- Cutaneous: Open abdomen increases loss significantly
3. Third Space Losses (Redistribution):
- Definition: Fluid shifts from intravascular to interstitial (non-functional)
- Sites: Surgical trauma, inflammation, bowel obstruction
- Estimates:
- Minor surgery: 0-2 mL/kg/hour
- Moderate surgery: 2-4 mL/kg/hour
- Major surgery: 4-8 mL/kg/hour
- Open abdomen: Up to 10-15 mL/kg/hour
- Replacement: Isotonic crystalloid
Fluid Choice:
Crystalloids:
- 0.9% Sodium Chloride (Normal Saline):
- 154 mmol/L Na⁺, 154 mmol/L Cl⁻
- Pros: Cheap, compatible with blood, isotonic
- Cons: Hyperchloremic metabolic acidosis (dilutional), renal vasoconstriction
- Hartmann's (Lactated Ringer's):
- 131 Na⁺, 111 Cl⁻, 5 K⁺, 2 Ca²⁺, 29 lactate (converts to bicarbonate)
- Pros: Balanced, less acidosis
- Cons: Slightly hypotonic, calcium precipitates with citrate (blood)
- Plasma-Lyte 148:
- 140 Na⁺, 98 Cl⁻, 5 K⁺, 1.5 Mg²⁺, 23 gluconate, 27 acetate
- Pros: Balanced, no calcium, acetate/gluconate metabolized to bicarbonate
- Cons: More expensive
Colloids:
- Albumin (4%, 20%):
- Pros: Expands intravascular volume effectively
- Cons: Expensive, blood product (theoretical risks), no survival benefit shown
- Hydroxyethyl Starch (HES):
- Avoid: Nephrotoxic, coagulopathy, mortality concern (6S, CHEST trials)
- Gelatins (Gelofusine):
- Pros: Cheap, effective short-term plasma expansion
- Cons: Allergic reactions, short duration
Blood Products:
- Indications:
- Hb <70 g/L (or <80-90 g/L if cardiovascular disease)
- Ongoing bleeding
- Symptomatic anemia
- Transfusion ratio (massive hemorrhage): 1:1:1 (PRBC:FFP:Platelets)
Glucose Management
Perioperative Considerations:
- Stress response: Hyperglycemia (catecholamines, cortisol, insulin resistance)
- Risk of hypoglycemia: If fasting on insulin/oral hypoglycemics
- Target: 6-10 mmol/L (avoid hypoglycemia and severe hyperglycemia)
Diabetes Management:
- Type 1: Must continue basal insulin (risk of DKA)
- Type 2: Stop metformin 48 hours pre-op if using contrast or if eGFR <60
- Monitoring: Regular BSLs, insulin sliding scale if needed
Postoperative Fluid Therapy
Goals:
- Maintain euvolemia
- Replace ongoing losses (NG tube, drains, fistulas)
- Restore electrolyte balance
- Transition to oral intake
Complications to Avoid:
- Fluid overload: Peripheral edema, pulmonary edema (especially in elderly, cardiac failure)
- Fluid restriction: Acute kidney injury, hypoperfusion
- Electrolyte disturbances: Monitor K⁺, Na⁺ daily, replace as needed
Indigenous Health Considerations
Aboriginal and Torres Strait Islander Patients
Higher Risk:
- Higher rates: Renal disease (affects fluid/electrolyte handling), diabetes (glucose management)
- Remote access: Dialysis-dependent patients may be far from centers
- Hospital presentation: Often dehydrated or fluid overloaded
Cultural Considerations:
- Kidney health: High importance in Aboriginal communities (high ESKD rates)
- Medication adherence: Complex regimens (fluid/electrolyte management in dialysis)
- Communication: Explain fluid restrictions clearly
Māori Health Considerations
Health Disparities:
- Higher rates of diabetes and renal disease
- Access to nephrology and dialysis services
Cultural Safety:
- Whānau involvement: Family support for patients on dialysis (fluid/diet restrictions)
- Communication: Clear explanation of fluid balance concepts
- Dietary support: Low-sodium, fluid-restricted diets (culturally appropriate)
ANZCA Primary Exam Focus
Key Concepts
Body Water Distribution:
- TBW: 60% (males), 50% (females)
- ICF: 40% body weight (2/3 TBW)
- ECF: 20% body weight (1/3 TBW)
- ISF: 15%
- Plasma: 5%
Electrolytes:
- Na⁺: 135-145 mmol/L (ECF osmolality, volume)
- K⁺: 3.5-5.0 mmol/L (resting membrane potential)
- Ca²⁺: 2.2-2.6 mmol/L total (neuromuscular, cardiac)
- Mg²⁺: 0.75-0.95 mmol/L (enzyme cofactor)
Osmolality:
- Normal: 285-295 mOsm/kg
- Formula: 2[Na⁺] + glucose/18 + urea/2.8
- Tonicity: Effective osmoles (Na⁺, glucose) vs ineffective (urea)
Fluid Therapy:
- Maintenance: 4-2-1 rule
- Fasting deficit: Calculate and replace
- Third space: 0-8 mL/kg/hour depending on surgery
- Blood loss: 3:1 crystalloid or 1:1 colloid/blood
Common Exam Questions
"Calculate the fluid deficit for a 70 kg man fasting 10 hours."
- Hourly maintenance: (10×4) + (10×2) + (50×1) = 40 + 20 + 50 = 110 mL/hour
- Deficit: 110 × 10 = 1100 mL
- Replace: 550 mL in first hour, 275 mL in hours 2 and 3
"Why is normal saline not 'normal'?"
- Na⁺ 154 mmol/L (higher than plasma 140)
- Cl⁻ 154 mmol/L (higher than plasma 100)
- Results in hyperchloremic metabolic acidosis (dilutional)
- Hartmann's or Plasma-Lyte more "physiological"
"What are the Starling forces governing capillary fluid exchange?"
- Outward: Capillary hydrostatic pressure (Pc), interstitial oncotic pressure (πi)
- Inward: Interstitial hydrostatic pressure (Pi), capillary oncotic pressure (πc)
- Net filtration = (Pc + πi) - (Pi + πc)
- Arterial end: Net filtration (+13 mmHg)
- Venous end: Net reabsorption (-2 mmHg)
- Lymphatics return excess interstitial fluid
"How does acid-base status affect potassium?"
- Acidosis: H⁺ enters cells, K⁺ exits to maintain electroneutrality → hyperkalemia
- Alkalosis: H⁺ exits cells, K⁺ enters → hypokalemia
- Clinical: Correct acidosis gradually to avoid rapid K⁺ shifts
References
- ANZCA. Primary Examination Syllabus. Physiology Section.
- Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. McGraw-Hill; 2001.
- Campbell D et al. Fluid management. BJA Educ. 2015;15(3):118-123.
- Hahn RG. Fluid therapy in clinical medicine. BJA. 2021;126(2):417-424.
- Lobo DN et al. Perioperative fluid management. BMJ. 2011;342:d1736.
- Miller RD et al. Miller's Anesthesia. 9th ed. Elsevier; 2020:1755-1780.
- Grocott MPW et al. Perioperative fluid management. N Engl J Med. 2005;353(11):1077-1080.
- ATSI Health. Chronic kidney disease in Aboriginal and Torres Strait Islander peoples. Australian Institute of Health and Welfare; 2020.